Feasibility of 18F-FDG PET as a noninvasive diagnostic tool of muscle denervation: a preliminary study

J Nucl Med. 2014 Oct;55(10):1737-40. doi: 10.2967/jnumed.114.140731. Epub 2014 Aug 7.

Abstract

The purpose of this study was to confirm glucose hypermetabolism in denervated muscle and investigate the feasibility of (18)F-FDG PET scanning for the detection of muscle denervation.

Method: A sciatic neuropathy model in rats was created by nerve resection of the left sciatic nerve and sham operation on the other side. Eight days after denervation, small-animal PET/CT scans of the hindlimbs were acquired. Muscle denervation was confirmed by electrophysiologic and histologic study.

Results: All rats showed increased (18)F-FDG uptake in the muscles of the left (denervated) lower legs. The calculated maximum lesion-to-normal counts ratio of the left lower leg anterolateral (left, 11.02 ± 2.08; right, 1.81 ± 0.40, n = 6, P < 0.01) and posterior (left, 9.81 ± 4.58; right, 1.87 ± 0.44, n = 6, P < 0.01) compartment were significantly increased. The electrophysiologic and histologic study verified muscle denervation.

Conclusion: Glucose hypermetabolism in muscle denervation is an obvious phenomenon. (18)F-FDG PET scanning can be used to visualize muscle denervation.

Keywords: 18F-FDG; muscle denervations; positron emission tomography; sciatic neuropathies.

MeSH terms

  • Animals
  • Electrophysiology
  • Feasibility Studies
  • Fluorodeoxyglucose F18*
  • Glucose / metabolism*
  • Immunohistochemistry
  • Male
  • Muscle Denervation*
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals*
  • Rats
  • Rats, Sprague-Dawley
  • Sciatic Nerve / diagnostic imaging
  • Sciatic Nerve / pathology
  • Tomography, X-Ray Computed / methods

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Glucose